Safety and Efficacy of Neoadjuvant Gemcitabine plus Carboplatin Followed by Immediate Cystectomy in Patients with Muscle-Invasive Bladder Cancer: A Propensity Score Analysis

被引：0
|
作者：
Koie, T. [1 ]
Okamoto, A. [1 ]
Tobisawa, Y. [1 ]
Yoneyama, T. [1 ]
Mori, K. [1 ]
Yamamoto, H. [1 ]
Hatakeyama, S. [1 ]
Yoneyama, T. [1 ]
Hashimoto, Y. [1 ]
Ohyama, C. [1 ]
机构：
[1] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori, Japan
来源：
UROLOGY | 2012年 / 80卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
EP.044
引用
收藏
页码：S205 / S205
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer: A propensity score analysis
    Koie, Takuya
    Okamoto, Teppei
    Suzuki, Yuichiro
    Tobisawa, Yuki
    Yoneyama, Tohru
    Mori, Kazuyuki
    Yamamoto, Hayato
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Kamimura, Noritaka
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [2] Neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer: A propensity score analysis
    Koie, T.
    Okamoto, T.
    Suzuki, Y.
    Tobisawa, Y.
    Yoneyama, T.
    Mori, K.
    Yamamoto, H.
    Hatakeyama, S.
    Kudoh, S.
    Yoneyama, T.
    Kamimura, N.
    Ohyama, C.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E867 - U826
  • [3] NEOADJUVANT GEMCITABINE PLUS CARBOPLATIN FOLLOWED BY IMMEDIATE RADICAL CYSTECTOMY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A PROPENSITY SCORE ANALYSIS
    Koie, Takuya
    Okamoto, Akiko
    Yamamoto, Hayato
    Tobisawa, Yuki
    Yoneyama, Tohru
    Mori, Kazuyuki
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Kamimura, Noritaka
    Ohyama, Chikara
    JOURNAL OF UROLOGY, 2012, 187 (04): : E217 - E218
  • [4] Neoadjuvant chemotherapy with gemcitabine plus carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer
    Ohyama, Chikara
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Koie, Takuya
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (01) : 3 - 4
  • [5] Neoadjuvant gemcitabine and carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer patients ineligible for cisplatin-based chemotherapy: A propensity score-matched analysis
    Koie, Takuya
    Ohyama, Chikara
    Imai, Atsushi
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [6] NEOADJUVANT GEMCITABINE AND CARBOPLATIN FOLLOWED BY IMMEDIATE RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER PATIENTS INELIGIBLE FOR CISPLATIN-BASED CHEMOTHERAPY: A PROPENSITY SCORE-MATCHED ANALYSIS
    Koie, Takuya
    Ohyama, Chikara
    Imai, Atsushi
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Yoneyama, Tohru
    Tobisawa, Yuki
    JOURNAL OF UROLOGY, 2016, 195 (04): : E668 - E668
  • [7] Can neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy improve survival in patients with cisplatin-ineligible muscle-invasive bladder cancer?
    Koie, Takuya
    Suzuki, Yuichiro
    Tobisawa, Yuki
    Yoneyama, Tohru
    Mori, Kazuyuki
    Okamoto, Akiko
    Yamamoto, Hayato
    Imai, Atsushi
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy
    Murasawa, Hiromi
    Koie, Takuya
    Ohyama, Chikara
    Yamamoto, Hayato
    Imai, Atsushi
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Iwabuchi, Ikuya
    Ogasawara, Masaru
    Kawaguchi, Toshiaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (01) : 159 - 165
  • [9] The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy
    Hiromi Murasawa
    Takuya Koie
    Chikara Ohyama
    Hayato Yamamoto
    Atsushi Imai
    Shingo Hatakeyama
    Takahiro Yoneyama
    Yasuhiro Hashimoto
    Ikuya Iwabuchi
    Masaru Ogasawara
    Toshiaki Kawaguchi
    International Journal of Clinical Oncology, 2017, 22 : 159 - 165
  • [10] PHASE 2 TRIAL OF NEOADJUVANT GEMCITABINE AND CARBOPLATIN FOR MUSCLE-INVASIVE BLADDER CANCER FOLLOWED BY RADICAL CYSTECTOMY
    Koie, Takuya
    Okamoto, Teppei
    Imanishi, Kengo
    Sugiyama, Naoki
    Kudoh, Shigemasa
    Mori, Kazuyuki
    Tachiwada, Tokushi
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Kamimura, Noritaka
    Ohyama, Chikara
    Suzuki, Yuichiro
    JOURNAL OF UROLOGY, 2010, 183 (04): : E657 - E657
12345